Molecular Partners Ag (MOLN) Non-Current Deffered Revenue (2020 - 2022)

Molecular Partners Ag (MOLN) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $3.8 million as the latest value for Q4 2022.

  • Quarterly Non-Current Deffered Revenue fell 49.73% to $3.8 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2022, down 49.73% year-over-year, with the annual reading at $3.8 million for FY2022, 50.18% down from the prior year.
  • Non-Current Deffered Revenue for Q4 2022 was $3.8 million at Molecular Partners Ag, down from $7.5 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $7.5 million in Q4 2021, with the low at $3.3 million in Q4 2020.
  • Average Non-Current Deffered Revenue over 3 years is $4.8 million, with a median of $3.8 million recorded in 2022.
  • The sharpest move saw Non-Current Deffered Revenue soared 131.01% in 2021, then tumbled 49.73% in 2022.
  • Over 3 years, Non-Current Deffered Revenue stood at $3.3 million in 2020, then skyrocketed by 131.01% to $7.5 million in 2021, then crashed by 49.73% to $3.8 million in 2022.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $3.8 million, $7.5 million, and $3.3 million for Q4 2022, Q4 2021, and Q4 2020 respectively.